Investigating the impact of fluid removal speed on heart strain during dialysis
Official title: The Effect of Hemodialysis on proBNP
Run by Umeå University · NCT06153888 · Data updated 2026-11-12
This study tests if changing how quickly fluid is removed during dialysis can help reduce heart strain in adults who have gained weight between treatments.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Umeå University Academic / other |
| Locations | 1 site (Umeå) |
| Status | Recruiting |
| Started | March 20, 2023 |
| Main results expected | March 30, 2026 |
| Study ends | April 30, 2026 |
| Registry record updated | December 16, 2024 |
| Trial ID | NCT06153888 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adult hemodialysis patients with significant inter-dialytic weight gain of 2.5% or more of their target weight.
✕Probably not a fit
Patients with active systemic inflammatory conditions or uncontrolled hyperphosphatemia may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study examines how the rate of fluid removal during chronic hemodialysis affects the release of cardiac markers, specifically NT-proBNP, which is associated with heart strain. By analyzing patients who experience significant inter-dialytic weight gain, the research aims to determine if adjusting the ultrafiltration rate could improve cardiovascular outcomes. The findings may lead to updated guidelines for dialysis prescriptions to better manage fluid overload and reduce cardiac risks in patients. The study involves adult patients undergoing hemodialysis and focuses on their physiological responses during treatment.
Why it matters
Potential benefit: If successful, this study could lead to improved dialysis prescriptions that reduce cardiovascular risks for patients with fluid overload.
How similar studies have gone: While there is ongoing research in this area, the specific approach of correlating ultrafiltration rates with cardiac strain markers is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult HD patients with an intra-dialytic weight gain (IDWG) ≥2.5% of target weight over the long interval (3 days) prior to inclusion. * Patients need to be able to understand the study information * Patients need to be able to give consent. Exclusion Criteria: * Active systemic inflammatory state such as extensive malignancy or acute septic infection. * Uncontrolled hyperphosphatemia decided by the local routine of the physician (due to somewhat decreased efficacy of the low flux filter to eliminate phosphate)
Where it's running
-
Region Vasterbotten, Norrlands Universitetssjukhus, Dialysen
Umeå, Sweden Recruiting
Study contacts
- Principal investigator: Bernd Stegmayr, MD, PhD — Umea University, Umea, Sweden
- Study coordinator: Bernd Stegmayr, MD, PhD
- Email: bernd.stegmayr@umu.se
- Phone: +46706264533
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Timing of kidney treatment in critically ill patients
This study is trying to find out if starting kidney treatment earlier can help critically ill patients with kidney injury feel better and have better outcomes.
-
Italian Registry of Pediatric Dialysis: collecting data from kids on kidney replacement therapy
This registry in Italy tests how collecting epidemiological, clinical, and treatment data from children on dialysis or pre-emptive kidney transplants can help centers share protocols and improve care.
-
3D Ultrasound Support for Hemodialysis Cannulation
This study tests whether the EchoMap device can help safely cannulate an arm fistula during hemodialysis for adults.
-
Using a bioimpedance device to track fluid status in children after stem cell transplant
The study tests whether bedside bioimpedance measurements can reliably track body water changes in children undergoing stem cell transplantation, alongside standard fluid checks.
-
Personalized High-Rate Fluid Removal Guided by Ultrasound in Hospitalized ESRD with Fluid Overload
This trial tests whether using ultrasound to guide a higher rate of fluid removal is as safe and effective as standard fluid removal for adults with end-stage kidney disease who are admitted for severe fluid overload.
-
Understanding how patients tolerate fluid removal during kidney support in the ICU
This observational study tests how well critically ill adults with acute kidney injury tolerate net fluid removal during continuous renal replacement therapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.